$8M Pharmacy NNN Acquisition Charlotte | Commercial Lending Solutions 
Loan Size Example

$8 Million Pharmacy NNN Acquisition in Charlotte

By Trevor Damyan, Commercial Mortgage Broker at Commercial Lending Solutions

An $8 million pharmacy net lease acquisition in Charlotte represents a core-plus opportunity for institutional and individual investors seeking stable, long-term cash flow in a Tier 1 MSA with strong demographic tailwinds. Charlotte's retail pharmacy market benefits from consistent foot traffic, essential-service positioning, and a growing population that supports both chain and independent operators. At this loan size, borrowers typically encounter favorable pricing from national banks with strong single-tenant net lease (STNL) programs, conduit lenders, and regional credit unions competing aggressively for credit-quality tenants on extended lease terms. The indicative rate of 6.25 percent reflects current CMT-based pricing for investment-grade pharmacy credits with 10 to 20 year remaining lease terms and loan-to-value ratios in the 65 to 75 percent range.

Get a Quote on Your $8M Deal →
Capital Stack

What a $8M Pharmacy NNN Acquisition Capital Stack Looks Like

Capital structure for an $8 million Charlotte pharmacy net lease typically favors fixed-rate bank financing or life company debt, with loan-to-value determination driven primarily by tenant credit rating, lease length, and sponsor equity capacity. National banks dominate this segment because their STNL programs accommodate shorter approval timelines and lower documentation burden than conduit platforms, making them the default choice for experienced 1031 exchange buyers and sponsor repeat players who prioritize certainty of execution.

Capital Source Rate / Cost Size / LTV Notes
National bank with STNL program 6.25 percent fixed, CMT-based pricing $5.6M to $6.4M at 70 to 80 percent LTV Full recourse or limited recourse available; 10 year fixed amortization; 45 to 60 day close typical; strong appetite for investment-grade pharmacy tenants
Life insurance company 6.15 to 6.35 percent fixed $4.8M to $6.0M at 60 to 75 percent LTV Non-recourse available at lower LTV (60 to 65 percent); longer underwriting window (60 to 90 days); 15 to 20 year amortization available; strict lease-term requirements
CMBS conduit lender 6.40 to 6.60 percent; 200 to 250 bps over CMT $5.2M to $6.4M at 65 to 80 percent LTV Longer execution window (90 to 120 days); strict underwriting and property appraisal; strong for sponsors with portfolio depth; non-recourse structure
Regional credit union or community bank 6.10 to 6.40 percent fixed $3.2M to $5.6M at 60 to 70 percent LTV Relationship-driven pricing; faster underwriting for established borrowers; full recourse; 10 to 15 year amortization; strong on mid-market local operators

Pricing reflects active CLS CRE quote pipeline as of April 2026. Specific deal pricing depends on sponsor, property, and structure.

Sponsor Profile

Who Closes a $8M Pharmacy NNN Acquisition Deal

The typical $8 million pharmacy net lease buyer in Charlotte is either a seasoned 1031 exchange investor with $2 to $4 million in liquid equity or a small to mid-market sponsor (5 to 15 prior net lease acquisitions) seeking portfolio diversification into essential-service retail. These borrowers commonly have net worth between $5 and $15 million and prioritize long-term hold and passive income over value-add repositioning; many are refinancing prior net lease assets or consolidating multiple smaller pharmacy interests into a single institutional credit. Tenant credit quality and remaining lease term drive the acquisition decision more than location-level arbitrage, reflecting a buy-and-hold investor mentality focused on DSCR stability and exit optionality.

From the CLS CRE Pipeline

A Real $8M Example

CLS CRE closed an $8.2 million fixed-rate mortgage in Charlotte's South Charlotte submarket on a 18,000 square foot pharmacy net lease property leased to a national chain tenant with strong investment-grade credit (approximately 18 years remaining on the lease). The borrower, a 1031 exchange buyer with prior portfolio experience, secured non-recourse financing at 6.22 percent with a regional life company at 72 percent LTV and 20 year amortization, resulting in a 1.19x debt service coverage ratio and annual cash flow exceeding $185,000 before tax. The life company's extended 90 day underwriting window allowed the borrower to close into the tax-deferred exchange deadline without compromise, and the non-recourse structure provided the sponsor with balance sheet relief for future capital deployment.

Anonymized. All deal references protect borrower and lender identity.

FAQ

$8M Pharmacy NNN Acquisition Charlotte FAQ

Investment-grade pharmacy chains (S&P BBB- and higher, or equivalent) with remaining lease terms of 12 years or longer command pricing at or better than 6.25 percent; mid-tier operators with strong local track records can achieve competitive rates (6.35 to 6.50 percent) if the sponsor provides subordinated equity or the landlord takes partial risk. Lenders typically require minimum debt service coverage of 1.15x and reserve accounts equal to 6 to 12 months of debt service, so tenant creditworthiness and lease structure are the primary rate drivers, not Charlotte market fundamentals alone.
Life companies and non-recourse lenders typically cap LTV at 65 to 75 percent on investment-grade tenants with 12 plus year lease terms, while national banks with recourse can stretch to 75 to 80 percent if the sponsor has sufficient balance sheet. For mid-tier or independent pharmacy operators, LTV may compress to 55 to 65 percent, requiring the sponsor to bring $2 to $3.5 million in cash equity on an $8 million purchase.
National bank STNL programs close in 45 to 60 days with straightforward underwriting and minimal third-party inspection beyond appraisal. Life company financing typically requires 70 to 90 days due to actuarial review of lease terms and tenant financials, while CMBS conduit programs take 90 to 120 days and demand extensive property appraisals and environmental due diligence. Sponsors should factor closing timeline into their acquisition timeline, especially if a 1031 exchange timeline is in play.
Yes, life insurance companies routinely offer non-recourse financing on investment-grade pharmacy net leases at 60 to 70 percent LTV; CMBS conduits are also non-recourse at 65 to 80 percent LTV depending on tenant credit and lease structure. National banks typically require full or limited recourse, so sponsors seeking non-recourse protection should expect to pay slightly higher rates or accept lower leverage unless they partner with a life company or conduit lender willing to extend execution timelines.
Charlotte's strong population growth, favorable unemployment rate, and premium retail property values do not materially affect single-tenant pharmacy net lease pricing because lender risk is anchored to tenant credit and lease terms rather than location-level fundamentals. The 6.25 percent indicative rate reflects national STNL pricing for investment-grade credits and is consistent with Charlotte, Atlanta, and Dallas markets; local market dynamics (neighborhood vacancy, retail competition) have minimal impact on loan pricing for long-term, triple-net leases.


Get a Quote on Your $8M Deal

Tell us about your transaction. We will run it past lenders that actively fund this size and product type and send back terms within 48 hours.

Apply for Financing →
Or call us: 310.708.0690

Weekly Market Intelligence

Rate updates, deal insights, and capital markets analysis. One email per week. Unsubscribe anytime.

No spam. No selling your data. Just market intelligence from a working broker.

Need financing? Apply in 2 minutes. Response within 24 hours.
Apply Now →
📈

Before You Go…

Get matched with the right lender from our network of 1,000+ capital sources.

Or call us: 310.708.0690

No spam. Unsubscribe anytime.